Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
299
datasets available to search
ShareScore release 0.9.0
Dataset results
299 results for “Prognostic factors”
Long-term outcomes and prognostic factors in kidney transplant recipients in Jakarta, Indonesia: a cohort study
<p><strong>Objectives </strong>To determine the long-term survival rates and prognostic factors in kidney transplant (KT) recipients in Jakarta, Indonesia.</p> <p><strong>Design</strong> Retrospective cohort study.</p> <p><strong>Setting</strong> A KT centre in Jakarta.</p> <p><strong>Participants</strong> We enrolled 754 consecutive adult recipients who underwent KT between 2010 and 2020.</p> <p><strong>Main outcome measures </strong>Rates of 10-year patient, all-cause and death-censored graft survival and their prognostic factors in KT recipients.</p> <p><strong>Results </strong>The 10-year patient survival, all-cause survival and death-censored graft survival rates of KT recipients were 74%, 68% and 81%, respectively. The prognostic factors for poor patient survival were a pretransplant dialysis duration>24 months (HR 1.64, 95% CI, 1.08 to 2.49; p=0.02), cardiovascular disease (HR 1.59, 95% CI, 1.11 to 2.31; p=0.01), delayed graft function (DGF) (HR 4.94, 95% CI, 2.76 to 8.82; p<0.001), post-transplant infection (HR 2.63, 95% CI, 1.56 to 4.43; p<0.001) and acute rejection (HR 2.49, 95% CI, 1.20 to 5.15; p=0.01). All-cause graft survival was prognosticated by a pretransplant dialysis duration>24 months (HR 1.74, 95% CI, 1.15 to 2.47; p=0.007), cardiovascular disease (HR 1.65, 95% CI, 1.18 to 2.33; p=0.004), DGF (HR 5.39, 95% CI, 3.13 to 9.28; p<0.001), post-transplant infection (HR 2.46, 95% CI, 1.05 to 4.02; p<0.001) and acute rejection (HR 4.18, 95% CI, 2.23 to 7.84; p<0.001). Factors associated with poor death-censored graft survival were a pretransplant dialysis duration >24 months (HR 2.19, 95% CI, 1.32 to 3.63; p=0.002), cardiovascular disease (HR 1.65, 95% CI, 1.02 to 2.68; p=0.04) and acute rejection (HR 5.52, 95% CI, 2.80 to 10.83; p<0.001).</p> <p><strong>Conclusions </strong>The survival rates of KT recipients are prognosticated by pretransplant dialysis duration, cardiovascular disease, DGF, post-transplant infection and acute rejection. Stricter eligibility criteria for recipients, more sensitive cross-match testing methods and better infection management strategies may be beneficial for improving the survival rates.</p>
Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT01369784. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Is TIme From adMission to surgEry an Independent Prognostic Factor for Survival of Patients With Gastro-intestinal Perforation Associated With Septic Shock: (TIME) An Italian Intersocietary Retrospect
ClinicalTrials.gov study NCT04811755. IPD Sharing: NO. Countries: 0. Publications: 4.
Clinical and Pathological Characteristics as Prognostic Factors in Locally Advanced Cervical Cancer
ClinicalTrials.gov study NCT04537273. IPD Sharing: YES. Countries: 0. Publications: 1.
Circadian as A Prognostic Factor For Radiation Response in Cervical Cancer
ClinicalTrials.gov study NCT05511740. IPD Sharing: YES. Countries: 0. Publications: 4.
A Retrospective Study of Prognostic Factors and Survival of Breast Cancer Patients with Brain Metastesis
ClinicalTrials.gov study NCT06723132. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting
ClinicalTrials.gov study NCT03912883. IPD Sharing: NO. Countries: 0. Publications: 37.
Prognostic Factors for Descending Necrotizing Mediastinitis Development in Deep Space Neck Infections
ClinicalTrials.gov study NCT04865003. IPD Sharing: UNDECIDED. Countries: 0. Publications: 6.
Prognostic Factors for Surgical Management of Large Hypertensive Basal Ganglionic Haemorrhage
ClinicalTrials.gov study NCT06309940. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Prognostic Factors in Patients Submitted to Surgical Treatment for Thymoma
ClinicalTrials.gov study NCT04577495. IPD Sharing: NO. Countries: 0. Publications: 10.
Clinical Outcomes and Prognostic Factors in Multiple Myeloma Patients
ClinicalTrials.gov study NCT06457464. IPD Sharing: Not stated. Countries: 0. Publications: 4.
Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors
ClinicalTrials.gov study NCT05168631. IPD Sharing: UNDECIDED. Countries: 2. Publications: 15.
Evaluation of Prognostic Factors in Tympanoplasty
ClinicalTrials.gov study NCT03416725. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Risk Factors and Prognostic Parameters of Interstitial Lung Disease in Children
ClinicalTrials.gov study NCT06125288. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Frequency ,Etiology and Prognostic Factors of Acute Transverse Myelitis
ClinicalTrials.gov study NCT06055998. IPD Sharing: Not stated. Countries: 0. Publications: 13.
PiA: Prognosis Used Every Day for Patients With Operable Breast Cancer - Comparison of Invasion Factors uPA/PAI-1 With Other Prognostic Factors
ClinicalTrials.gov study NCT01592825. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Serum Electrolyte Abnormalities as Prognostic Factor for Outcome in Critically Ill Children
ClinicalTrials.gov study NCT07205562. IPD Sharing: UNDECIDED. Countries: 0. Publications: 4.
Prognostic Factors in NOP-LBBB After TAVI
ClinicalTrials.gov study NCT05654792. IPD Sharing: NO. Countries: 0. Publications: 10.
Clinicopathological Features , Outcomes and Prognostic Factors of High Risk Patients of Gestational Trophoblastic Neoplasia
ClinicalTrials.gov study NCT06900699. IPD Sharing: NO. Countries: 0. Publications: 9.
Prognostic Factors After Liver Transplantation
ClinicalTrials.gov study NCT05018741. IPD Sharing: NO. Countries: 0. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.